Slovakia
Cyxone screens first patient in Phase II Covid-19 trial
Cyxone has announced the screening of the first participant in the Phase II clinical trial to evaluate Rabeximod for treating Covid-19 patients.
Cyxone has announced the screening of the first participant in the Phase II clinical trial to evaluate Rabeximod for treating Covid-19 patients.